TrialDiabetes care2018

Genetic Tools for Coronary Risk Assessment in Type 2 Diabetes: A Cohort Study From the ACCORD Clinical Trial.

Mario Luca Morieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.